The new results, issued via press release, show that patients who injected themselves with either 80 milligrams or 160 mg of Arcalyst once a week had a 72% decrease in the average number of gout flares compared to a placebo group.

FORBES: Regeneron Announces Strong Results In Gout Study

Patients will either receive 40 milligrams of Zocor, the second-highest dose, or a dose of Vytorin that combines 40 mg of Zocor with 10 mg of Zetia.

FORBES: Merck, Schering Launch Huge Heart-Drug Test